The usefulness of C-reactive protein and neutrophil-to-lymphocyte ratio for predicting the outcome in hospitalized patients with liver cirrhosis

被引:57
作者
Kwon, Jung Hyun [1 ]
Jang, Jeong Won [2 ]
Kim, Young Woon [1 ]
Lee, Sung Won [3 ]
Nam, Soon Woo [1 ]
Jaegal, Dongwook [4 ]
Lee, Seungok [4 ]
Bae, Si Hyun [2 ]
机构
[1] Catholic Univ Korea, Dept Internal Med, Incheon St Marys Hosp, Inchon, South Korea
[2] Catholic Univ Korea, Dept Internal Med, Seoul St Marys Hosp, Seoul, South Korea
[3] Catholic Univ Korea, Dept Internal Med, Bucheon St Marys Hosp, Bucheon Si, Gyeonggi Do, South Korea
[4] Catholic Univ Korea, Incheon St Marys Hosp, Dept Lab Med, Inchon, South Korea
来源
BMC GASTROENTEROLOGY | 2015年 / 15卷
关键词
C-reactive protein; Liver cirrhosis; Infection; Neutrophil-to-lymphocyte ratio; Survival; SYSTEMIC INFLAMMATORY RESPONSE; BACTERIAL-INFECTIONS; NATURAL-HISTORY; SEPSIS; MORTALITY; INDICATOR; APOPTOSIS; SURVIVAL; FAILURE; ASCITES;
D O I
10.1186/s12876-015-0378-z
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The role of clinical parameters such as systemic inflammatory response syndrome (SIRS) criteria in predicting the infection remains unclear in cirrhosis patients. The aim was to evaluate the usefulness of inflammatory markers including C-reactive protein (CRP) and the neutrophil-to-lymphocyte ratio (NLR) for diagnosis of infection and predicting the outcomes in hospitalized cirrhotic patients. Methods: The study included 184 cirrhotic patients consecutively hospitalized from 2011 to 2012. The presence of overt infection and survival was evaluated. CRP concentration, NLR, Model for End-Stage Liver Disease (MELD) score and the presence of SIRS were assessed. Results: The main cause of admission was uncontrolled ascites (36.4 %), followed by varix bleeding (23.9 %), and hepatic encephalopathy (13.6 %). Fifty-eight patients (31.5 %) had overt infection during hospitalization and thirty-two patients (17.4 %) expired during the follow up period (median 38 months). Ninety-two patients (52.2 %) fulfilled the SIRS criteria and among them, only 32 patients (38.5 %) had the overt infection. For diagnose of the infection, baseline CRP concentration was a significant factor compared to the presence of SIRS (odds ratio 1.202, P = 0.003). For predicting one-month short-term survival, MELD score, NLR and WBC count were significant factors but in Child-Pugh class C patients, NLR was only an independent factor. Conclusions: CRP was a significant indicator of infection in hospitalized cirrhotic patients and a NLR was a useful predictor of 1-month survival, particularly in Child-Pugh class C patients. This study suggests that the inflammatory markers such as CRP and NLR can help identify cirrhotic patients at risk of unfavorable outcomes.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Neutrophil-to-lymphocyte ratio, white blood cell, and C-reactive protein predicts poor outcome and increased mortality in intracerebral hemorrhage patients: a meta-analysis
    Guo, Peixin
    Zou, Wei
    FRONTIERS IN NEUROLOGY, 2024, 14
  • [42] Prognostic value of the neutrophil-to-lymphocyte ratio and C-reactive-protein-to-prealbumin ratio in hospitalized older patients with coronavirus disease 2019
    Pan, Kenv
    Jin, Yujiao
    Du, Wei
    Wang, Miaochan
    Zhang, Yan
    Liu, Shourong
    Zhang, Yongle
    MEDICINE, 2024, 103 (16) : E37809
  • [43] Correlation between serum uric acid, C-reactive protein, and neutrophil-to-lymphocyte ratio in patients with psoriasis: A case-control study
    Mishra, Swayamsidda
    Kadnur, Manjunath
    Jartarkar, Shishira R.
    Keloji, Hanumanthayya
    Agarwa, Ritu
    Babu, Spoorthy
    TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2022, 56 (01): : 28 - 33
  • [44] Serum C-reactive protein and neutrophil-to-lymphocyte ratio as predictors of survival in cirrhotic patients with systemic inflammatory response syndrome and bacterial infection
    Ashishkumar Tapadia
    Mayank Jain
    Mettu Srinivas Reddy
    B. Mahadevan
    Joy Varghese
    Jayanthi Venkataraman
    Indian Journal of Gastroenterology, 2021, 40 : 265 - 271
  • [45] Diagnostic value of procalcitonin, hypersensitive C-reactive protein and neutrophil-to-lymphocyte ratio for bloodstream infections in pediatric tumor patients
    Li, Dongmei
    Li, Jie
    Zhao, Chuanxi
    Liao, Xianglu
    Liu, Lisheng
    Xie, Li
    Shang, Wenjing
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2023, 61 (02) : 366 - 376
  • [46] Neutrophil-to-lymphocyte ratio may be associated with the outcome in patients with prostate cancer
    Minardi, Daniele
    Scartozzi, M.
    Montesi, L.
    Santoni, M.
    Burattini, L.
    Bianconi, M.
    Lacetera, V.
    Milanese, G.
    Cascinu, S.
    Muzzonigro, G.
    SPRINGERPLUS, 2015, 4
  • [47] The Significance of Serum C-Reactive Protein and Neutrophil-Lymphocyte Ratio in Predicting the Diagnostic Outcomes of Renal Mass Biopsy Procedure
    Colakerol, Aykut
    Sahin, Sergen
    Yazar, Ramazan Omer
    Temiz, Mustafa Zafer
    Yuruk, Emrah
    Kandirali, Engin
    Semercioz, Atilla
    Muslumanoglu, Ahmet Yaser
    JOURNAL OF KIDNEY CANCER AND VHL, 2023, 10 (01): : 9 - 14
  • [48] Neutrophil-to-lymphocyte Ratio, Platelet-to-lymphocyte Ratio, and C-reactive Protein as New and Simple Prognostic Factors in Patients With Metastatic Renal Cell Cancer Treated With Tyrosine Kinase Inhibitors: A Systemic Review and Meta-analysis
    Semeniuk-Wojtas, Aleksandra
    Lubas, Arkadiusz
    Stec, Rafal
    Syrylo, Tomasz
    Niemczyk, Stanislaw
    Szczylik, Cezary
    CLINICAL GENITOURINARY CANCER, 2018, 16 (03) : E685 - E693
  • [49] Combined score of C-reactive protein level and neutrophil-to-lymphocyte ratio: A novel marker in distinguishing children with exacerbated asthma
    Zhu, Xuming
    Zhou, Lina
    Li, Qingqing
    Pan, Ruilin
    Zhang, Jian
    Cui, Yubao
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2021, 35
  • [50] The effect of biological agent treatment on neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, mean platelet volume, and C-reactive protein in psoriasis patients
    An, Isa
    Ucmak, Derya
    Ozturk, Murat
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2020, 37 (02): : 202 - 206